The prostatic urethral angle can predict the response to alpha adrenoceptor antagonist monotherapy for treating nocturia in men with lower urinary tract symptom: A multicenter study
- Byung Hoon Kim; Ki Ho Kim; Young Hwii Ko; Phil Hyun Song; Tae-Hwan Kim; Bum Soo Kim
- Dept. of Urology (비뇨의학)
- Issue Date
- Applications in Plant Sciences., Vol.4(1) : 30-35, 2016
- Background: We evaluated ultrasonography variables associated with the improvement of nocturia
after administration of alpha adrenoceptor antagonist (alpha blocker) monotherapy.
Methods: From February to October 2014, 679 men with lower urinary tract symptoms (LUTS) underwent
ultrasonography including prostate volume, transitional zone volume, prostatic urethral
length, the ratio between prostatic urethral length and prostate volume (RPUL), intravesical prostatic
protrusion (IPP), and prostatic urethral angle (PUA). Among them, 108 men who had pre-treatment
nocturia without nocturnal polyuria (nocturnal polyuria index < 33%) and were treated with alpha
blocker monotherapy over 3 months were enrolled. Patients were divided into the improved (< 2
times of nocturia) and non-improved group (more than 2 times) after administration of alpha blockers.
Along with ultrasonography, international prostate symptom score (IPSS) and uroflowmetry was
Results: After alpha blocker treatment, 25.0% of patients (27/108) showed improvement of nocturia.
These patients were significantly younger (59.6 vs 68.0 years, P ¼ < 0.001) with lower PUA (31.8 vs. 39.4 ,
P ¼ 0.009) compared with the non-improved group. In ROC analysis, the area under the curve using the
PUA was 0.653 (95% CI ¼ 0.532e0.774, P ¼ 0.018). Using 33.5 as a cut-off level, the sensitivity and
specificity for predicting the improvement of nocturia after medication reached 67.9% and 55.6%,
respectively. Patients with lower PUA (PUA < 33.5 ) had more improvement of nocturia (36.6 vs. 17.9%,
P ¼ 0.030), lower IPSS score (14.2 vs. 18.3, P ¼ 0.005), and better quality of life index (3.1 vs 3.8,
P ¼ 0.021).
Conclusions: In the patients with lower PUA (particularly lower than 33.5 ), nocturia was improved by
administration of alpha blocker monotherapy.
- Adrenergic alpha-antagonists; Benign prostatic hyperplasia; Nocturia; Prostate
- Appears in Collections:
- 1. Journal Papers (연구논문) > 1. School of Medicine (의과대학) > Dept. of Urology (비뇨의학)
- Keimyung Author(s)
- File in this Item
- oak-2016-0253.pdf(595.52 kB)Download
- RIS (EndNote)
- XLS (Excel)